Table 9.
GHR−/− WAT | GHR−/− plasma | GH deficiency | rhGH doping serum | bGH plasma | Acromegaly serum | HFD tissues | HFD plasma | Aging plasma | Aging WAT | |
---|---|---|---|---|---|---|---|---|---|---|
APOA1 | ↓ | ↑ | ↓ | ↓ | ↑ skin, stomach | ↑ | ||||
APOE | ↓ | ↑ | ↑ Skin | |||||||
APOA4 | ↑ | ↑ | ||||||||
TTR | ↑ | ↑ | ↓ | ↓ | ↑ | ↑ | ↑ | |||
HP | ↓ | ↓ | ↑ | ↓ | ↑ | |||||
HBB | ↑ | ↓ | ↓ | |||||||
RBP4 | ↑ | ↓ | ↑ | |||||||
A2M | ↓ | ↑↓ |
Shared proteins regulated by mouse or human models of GH excess or deficiency, including several apolipoproteins and inflammatory markers. Upward-pointing arrows indicate increased expression, whereas downward-pointing arrows indicate decreased expression. Arrows in both directions represent isoform-specificity, with total levels of the protein unchanged